However, in an experimental vascular dementia model (BCAS), NHE1 protein is shown to be upregulated in reactive astrocytes and pharmacological inhibition of NHE1 protein with its potent inhibitor HOE642 significantly attenuated astrogliosis and improved hippocampal integrity and cognitive function [141]. This evidence concerns the gene SLC9A1 and vascular dementia.